Cite

HARVARD Citation

    Seko, Y. et al. (2017). Effect of 12‐week dulaglutide therapy in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease and type 2 diabetes mellitus. Hepatology research. 47 (11), pp. 1206-1211. [Online]. 
  
Back to record